Biogen (NasdaqGS:BIIB) received Breakthrough Therapy Designation from the FDA for litifilimab in cutaneous lupus ...
Precedence Research, a leading strategic research firm, today released a comprehensive overview of the gene therapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results